Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein-Reference-Cited by-同舟云学术

Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein

Published:2004-04-20 Issue:9 Volume:172 Page:5561-5569
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Wang Ruobing,Epstein Judith,Charoenvit Yupin,Baraceros Fe Maria,Rahardjo Nancy,Gay Tanya,Banania Jo-Glenna,Chattopadhyay Rana,de la Vega Patricia,Richie Thomas L.,Tornieporth Nadia,Doolan Denise L.,Kester Kent E.,Heppner D. Gray,Norman Jon,Carucci Daniel J.,Cohen Joe D.,Hoffman Stephen L.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Potent Induction of Focused Th1‐Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a RecombinantPlasmodium falciparumMalaria Vaccine

2. A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalaria

3. Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalaria

4. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

5. Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malaria Vaccines: Progress to Date;BioDrugs;2023-09-20

2. Malaria Vaccines: From the Past towards the mRNA Vaccine Era;Vaccines;2023-09-04

3. mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum;npj Vaccines;2022-12-01

4. SILVI, an open-source pipeline for T-cell epitope selection;PLOS ONE;2022-09-07

5. Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses;3 Biotech;2022-08-23